Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-25

Clinical Trial Update: Staccato Prochlorperazine in Migraine (Out Patient) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Staccato Prochlorperazine in outpatient migraine shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Staccato Prochlorperazine (prochlorperazine)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Migraine Headache, Aura | Phase 2 | Status: COMPLETED | Results posted: 2018-01-25